Stockscreener 앱 받기
25.87
1.00%
-0.26
시간 외 거래:
25.87
전일 마감가:
$26.13
열려 있는:
$25.93
하루 거래량:
452.82K
Relative Volume:
0.97
시가총액:
$1.40B
수익:
$2.22M
순이익/손실:
$-40.51M
주가수익비율:
-20.14
EPS:
-1.2847
순현금흐름:
$-46.53M
1주 성능:
-5.31%
1개월 성능:
-6.77%
6개월 성능:
+130.98%
1년 성능:
+52.36%
1일 변동 폭
$25.00
$26.52
1주일 범위
$25.00
$28.01
52주 변동 폭
$5.14
$33.00
Upstream Bio Inc Stock (UPB) Company Profile
명칭
Upstream Bio Inc
전화
781-208-2466
주소
890 WINTER STREET, SUITE 200, WALTHAM
UPB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UPB
Upstream Bio Inc
|
25.87 | 1.41B | 2.22M | -40.51M | -46.53M | -1.2847 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Upstream Bio Inc Stock (UPB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-18 | 개시 | Mizuho | Outperform |
| 2025-11-18 | 개시 | Evercore ISI | Outperform |
| 2025-10-14 | 개시 | Truist | Buy |
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | Piper Sandler | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
모두보기
Upstream Bio Inc 주식(UPB)의 최신 뉴스
Upstream Bio (NASDAQ:UPB) Stock Price Down 6.2%What's Next? - MarketBeat
Upstream Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Upstream Bio Inc Stock Price ($UPB), Quote & News - eToro
Upstream Bio initiated with an outperform at Mizuho - MSN
AI Indicators Detect Buy Opportunity in Zenith Drugs LimitedCash Flow Trends & Outstanding Investment Returns - earlytimes.in
Geopolitics Watch: How Upstream Bio Inc stock reacts to Fed rate cutsWeekly Market Report & Fast Momentum Entry Tips - moha.gov.vn
Upstream Bio (NASDAQ:UPB) Shares Down 3.4%Time to Sell? - MarketBeat
Treasury Yields: How Upstream Bio Inc stock reacts to global recession fearsBuy Signal & Reliable Breakout Forecasts - moha.gov.vn
Upstream Bio Reports Progress in Respiratory Trials - MSN
Upstream Bio (NASDAQ:UPB) Stock Price Up 4.8%Should You Buy? - MarketBeat
Upstream Bio (UPB) price target decreased by 18.03% to 51.00 - MSN
Upstream Bio (UPB): NASDAQ Biotech Index Entry Sparks the Big Rerating Debate - parameter.io
Upstream Bio, Inc.(NasdaqGS: UPB) added to NASDAQ Biotechnology Index - marketscreener.com
Upstream Bio, Inc. (NASDAQ:UPB) Receives $45.25 Average Price Target from Brokerages - Defense World
Can Upstream Bio Inc. stock weather global recessionPortfolio Risk Report & Accurate Entry and Exit Point Alerts - Улправда
Why retail investors favor Upstream Bio Inc. stockWeekly Risk Summary & Low Volatility Stock Suggestions - Улправда
Does Mizuho’s New Coverage of Upstream Bio (UPB) Reframe the Stock’s Risk‑Reward Narrative? - Sahm
How Upstream Bio Inc. stock reacts to global recession fearsNew Guidance & Risk Controlled Swing Alerts - DonanımHaber
Will Upstream Bio Inc. stock beat EPS estimatesEarnings Growth Summary & Risk Adjusted Swing Trade Ideas - Улправда
Upstream Bio (NASDAQ:UPB) Stock Rating Upgraded by Mizuho - MarketBeat
Is Upstream Bio Inc. stock overvalued by current metricsTrade Analysis Summary & Weekly Sector Rotation Insights - Улправда
How Upstream Bio Inc. stock reacts to inflationary pressures2025 Sector Review & Risk Managed Investment Strategies - DonanımHaber
Will Upstream Bio Inc. stock maintain dividend yieldQuarterly Earnings Summary & Free Real-Time Market Sentiment Alerts - DonanımHaber
Will Upstream Bio Inc. stock benefit from green energy trends2025 Top Gainers & Expert-Curated Trade Recommendations - Улправда
Chipmakers Recap: Can Upstream Bio Inc. stock weather global recessionJuly 2025 Levels & Low Risk Investment Opportunities - Улправда
Upstream Bio, Inc. (NASDAQ:UPB) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Mizuho Initiates Coverage on UPB with Outperform Rating and $51 PT | UPB Stock News - GuruFocus
Mizuho initiates Upstream Bio stock with Outperform rating on asthma drug potential - Investing.com Canada
Upstream Bio initiated with an Outperform at Mizuho - TipRanks
Upstream Bio (NASDAQ:UPB) Stock Price Up 6.9%Time to Buy? - MarketBeat
Financial Analysis: Precision BioSciences (NASDAQ:DTIL) & Upstream Bio (NASDAQ:UPB) - Defense World
Bain Capital Life Sciences Investors LLC Raises Holdings in Upstream Bio, Inc. $UPB - MarketBeat
Norges Bank Acquires New Position in Upstream Bio, Inc. $UPB - MarketBeat
Can Upstream Bio Stock Hold Up When Markets Turn? - Trefis
Contrasting Upstream Bio (UPB) & The Competition - Defense World
Geode Capital Management LLC Buys 235,958 Shares of Upstream Bio, Inc. $UPB - MarketBeat
Lifesci Capital Predicts Upstream Bio FY2025 Earnings - Defense World
Upstream Bio: Maintaining Buy Rating On Verekitug Success In Phase 2 CRSwNP Study (UPB) - Seeking Alpha
UPB: Virectib's robust phase 2 results and unique mechanism set the stage for pivotal trials in 2026 - TradingView
Lifesci Capital Forecasts Upstream Bio FY2025 Earnings - MarketBeat
Upstream Bio (NASDAQ:UPB) Shares Down 8%Here's What Happened - MarketBeat
Stocks of Upstream Bio Inc (UPB) are poised to climb above their peers - setenews.com
Upstream Bio (NASDAQ:UPB) Coverage Initiated by Analysts at Lifesci Capital - MarketBeat
Upstream Bio (NASDAQ:UPB) Now Covered by Analysts at Lifesci Capital - Defense World
LifeSci Capital Initiates Coverage of Upstream Bio (UPB) with Outperform Recommendation - Nasdaq
Upstream Bio initiated with an Outperform at LifeSci Capital - TipRanks
Is Upstream Bio Inc. stock attractive for ETFsJuly 2025 Snapshot & Fast Moving Stock Watchlists - Newser
What analysts say about Upstream Bio Inc stockEarnings Miss Alerts & Free High Yield Market Plays - earlytimes.in
Severe Asthma Clinical Pipeline 2025: A Comprehensive Review of 50+ Emerging Therapies from 40+ Innovators, says DelveInsight - Barchart.com
You might want to take a look at Upstream Bio Inc (UPB) now - Setenews
Upstream Bio (NASDAQ:UPB) Shares Up 8.5%Should You Buy? - MarketBeat
Upstream Bio Inc (UPB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):